Les conférences de Généthon : 2018, mars 21

  • Le mercredi 21 mars 2018 :

«Recombinant AAV for Human Gene Therapy: Progress, Challenges and Perspectives for Vector Design, Manufacturing and Characterization»

Pr Fraser Wright, Co-Founder and Chief Technology Advisor / Officer at Spark Therapeutics, former Scientific Director, Clinical Vector Core at the University of Pennsylvania and former Director of Development and Manufacturing at Avigen.15